Welcome to the e-CCO Library!

DOP67: A transcriptional module associated with neutrophil degranulation is highly conserved across species and is a core molecular pathway of treatment resistance in ulcerative colitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Cozzetto, D.(1)*;Lo, J.(1);Powell, N.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP67: Comparison of the pharmacokinetics of CT-P13 between Crohn’s Disease and Ulcerative Colitis in biologic-naïve patients; a prospective multi-center observational study of the KASID
Year: 2021
Source: ECCO'21 Virtual
Authors: Kim, E.S.(1);Park, D.I.(2);Kim, H.J.(3);Lee, Y.J.(4);Koo, J.S.(5);Kim, E.S.(6);Yoon, H.(7);Lee, J.H.(8);Kim, J.W.(9);Shin, S.J.(10);Kim, H.W.(11);Kim, H.S.(12);Park, Y.S.(13);Kim, Y.S.(14);Kim, T.O.(15);Lee, J.(16);Choi, C.H.(17);Han, D.S.(18);Chun, J.(19);Kim, H.S.(20)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP67: First-line infliximab is cost-effective compared to conventional treatment in paediatric Crohn’s Disease – Results from the TISKids study
Year: 2022
Source: ECCO'22
Authors: Vuijk, S.(1);Jongsma, M.(1);Hoeven, B.(1);Cozijnsen, M.(1);van Pieterson, M.(1);de Meij, T.(2);Norbruis, O.(3);Groeneweg, M.(4);Wolters, V.(5);van Wering, H.(6);Hummel, T.(7);Stapelbroek, J.(8);van der Feen, C.(9);van Rheenen, P.(10);van Wijk, M.(2);Teklenburg, S.(3);Poleij, M.(11);Escher, J.(1);de Ridder, L.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP67: Magnification endoscopy with optical chromoendoscopy for in vivo assessment of histological inflammation in patients with inflammatory bowel disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

E. Klenske*1, R. Atreya1, A. Hartmann2, S. Fischer1, S. Hirschmann1, S. Zundler1, M. Iacucci3, M. Neurath1, T. Rath1

Created: Friday, 22 February 2019, 9:41 AM
DOP68 Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells via STAT3/IL-6 signal pathway
Year: 2020
Source:

ECCO'20 Vienna

Authors:

Y. XU1, M. zhang2, G. Xu2, X. Zou2

Created: Thursday, 30 January 2020, 10:12 AM
DOP68: Assessment of patients' understanding of Inflammatory Bowel Diseases (IBD): Development and validation of a questionnaire (U-IBDQ)
Year: 2021
Source: ECCO'21 Virtual
Authors: Ostromohov, G.(1);Fiebelman, M.(1,2);Hirsch, A.(1,3);Ron, Y.(1,3);Aviv Cohen , N.(1,3);Kariv , R.(1,3);Deutsch, L.(1,3);Anbar, R.(1,4);Maharshak, N.(3,5);Fliss Isakov, N.(1,6)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP68: Autophagy induction in the intestinal epithelium protects against inflammation-induced barrier loss in vivo.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Saha, K.(1)*;Ganapathy, A.S.(1);Wang, A.(1);Morris, N.(1);Yochum, G.(2);Koltun, W.(2);Ding, W.(2);Nighot, M.(1);Ma, T.(1);Nighot, P.(1);
Created: Friday, 14 July 2023, 10:43 AM
DOP68: CD-TREAT diet induces remission and improves quality of life in an open label trial in children and adults with active Crohn’s Disease
Year: 2022
Source: ECCO'22
Authors: Svolos, V.(1);Hansen, R.(1);Russell, R.(1);Gaya, D.R.(1);John Paul, S.(1);Macdonald, J.(1);Nichols, B.(1);Papadopoulou, R.(1);Logan, M.(1);Mckirdy, S.(1);Gervais, R.(1);Ijaz, U.(1);Milling, S.(1);Shields, S.(1);Wilson, D.(1);Henderson, P.(1);Din, S.(1);Ho, G.T.(1);Gerasimidis, K.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP68: Histological remission (NANCY index) is superior to endoscopic mucosal healing in predicting relapse-free survival in patients with ulcerative colitis in clinical and endoscopic remission
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

H. Wang*1, I. Fewings2, L. Bornman1, B. Shadbolt3, M. Fadia2, K. Subramaniam1,4

Created: Friday, 22 February 2019, 9:41 AM
DOP69 Tofacitinib in ulcerative colitis: Early ‘real-world’ experience from four UK tertiary centres
Year: 2020
Source:

ECCO'20 Vienna

Authors:

D. Chee1, S. Honap2, T.P. Chapman3, A.J. Kent4, M. Patel4, B. Hayee4, P. Dubois4, L. Medcalf4, E. Sharma5, Y. Begum5, S. Ray2, J. Kennedy3, S. Cripps6, C. Elworthy7, A. Walsh3, J.R. Goodhand1, T. Ahmad1, J. Satsangi3, N.A. Kennedy1, P. Irving2, LEO (London, Exeter, Oxford) Consortium - Travis S, Brain O, Palmer R

Created: Thursday, 30 January 2020, 10:12 AM
DOP69: Glycans as an actor in the microbiome-immune response crosstalk.
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rodrigues, C.(1);Gaifem, J.(2);Pereira, M.(2);Lavelle, A.(3);Colombel, J.F.(4);Sokol, H.(5);Pinho, S.(6)*;
Created: Friday, 14 July 2023, 10:43 AM
DOP69: Long-term outcome of infantile and very early onset IBD: A multi-center study from the IBD Porto group of ESPGHAN
Year: 2022
Source: ECCO'22
Authors: Guz Mark, A.(1,2);Aloi, M.(3);Scarallo , L.(4);Bramuzzo, M.(5);Escher, J.C.(6);Alvisi, P.(7);Henderson, P.(8);Hojsak, I.(9);Lev-Tzion, R.(10);El-Matary, W.(11);Schwerd, T.(12);Weiss, B.(13);Sladek, M.(14);Strisciuglio, C.(15);Müller, K.(16);Olbjørn, C.(17);Tzivinikos, C.(18);Yerushalmy-Feler, A.(19);Christiaens, A.(20);Norsa, L.(21);Viola, I.(22);de Ridder, L.(6);Shouval, D.(23);Lega, S.(5);Lionetti, P.(24);Catassi, G.(25);Assa, A.(26);
Created: Friday, 11 February 2022, 3:52 PM
DOP69: Ozanimod for induction treatment of Moderate-to-Severe Ulcerative Colitis: Results from a systematic literature review and network meta-analyses
Year: 2021
Source: ECCO'21 Virtual
Authors: Eaton, K.(1);Duperrouzel, C.(1);Bhandari, P.(1);Craigie, S.(1);Bonner, A.(1);Cameron, C.(2);Tencer, T.(3);Kumar, J.(3)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP69: The detection with targeted biopsy and characterisation of neoplastic lesions by magnifying chromoendoscopy and NBI in surveillance colonoscopy of patients with ulcerative colitis: a sub-analysis of the Navigator Study
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

K. Watanabe*1,2, M. Esaki3, S. Oka4, F. Shimamoto5, M. Nishishita2, T. Fukuchi6, S. Fujii7, F. Hirai8, K. Kakimoto9, T. Inoue9, H. Kashida10, K. Takeuchi11, N. Ohmiya12, M. Saruta13, S. Saito14, Y. Saito15, S. Tanaka16, Y. Ajioka17, H. Tajiri13

Created: Friday, 22 February 2019, 9:41 AM
DOP70 High-dimensional analysis reveals a novel signature for IL-17 producing CD8 T cells in inflammatory bowel disease
Year: 2020
Source:

ECCO'20 Vienna

Authors:

A.M. Globig1, P. Otto-Mora1, A. Hipp1, M. Heeg2, H. Schwacha1, V. Tomov3, R. Thimme1, P. Hasselblatt1, B. Bengsch1

Created: Thursday, 30 January 2020, 10:12 AM
DOP70: An integrated multi-omics biomarker predicting endoscopic response in ustekinumab treated patients with Crohn's disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

B. Verstockt*1,2, P. Sudahakar2,3,4, B. Creyns5, S. Verstockt6, J. Cremer5, W-J. Wollants2, S. Organe2, T. Korcsmaros3,4, M. Madgwick3, G. Van Assche1,2, C. Breynaert5, S. Vermeire1,2, M. Ferrante1,2

Created: Friday, 22 February 2019, 9:41 AM
DOP70: Anti-TNF withdrawal according to a risk-stratified protocol does not reduce the risk of relapse in patients with Inflammatory Bowel Disease in endoscopic remission: A prospective study
Year: 2022
Source: ECCO'22
Authors: Mahmoud, R.(1);Savelkoul, E.(2);Mares, W.(3);Goetgebuer, R.(4,5);Witteman, B.(3);de Koning, D.(6);Minderhoud, I.(7);van Tuyl, S.(8);van Boeckel, P.(9);Mahmmod, N.(9);Lutgens, M.(10);Horjus, C.(11);Römkens, T.(12);Akol-Simsek, D.(13);Jansen, J.(14);Hoentjen, F.(2,15);Jharap, B.(16);Oldenburg, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
DOP70: Crohn's Disease Like Inflammation of The Pouch is a Distinct Type of Pouchitis
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kayal, M.(1)*;Tankelevich, M.(2);Guo, Y.(3);Fischer, J.(4);Jimenez, D.(5);Canales-Herrerias, P.(2);Livanos, A.(2);Colombel, J.F.(1);Dubinsky, M.(6);Faith, J.(4);Ko, H.(3);Mehandru, S.(2);
Created: Friday, 14 July 2023, 10:43 AM
DOP70: Exosomes derived from human umbilical cord mesenchymal stem cells to attenuate colitis through repairing intestinal mucosal barrier
Year: 2021
Source: ECCO'21 Virtual
Authors: Yang, S.(1);Liang, X.(1);Liu, A.(1);Zhang, X.(1)
Created: Wednesday, 2 June 2021, 4:12 PM
DOP71 Efficacy, safety, and tolerability of ustekinumab in paediatric patients with moderately to severely active Crohn’s disease: Results from, UniStar, a phase 1 study
Year: 2020
Source:

ECCO'20 Vienna

Authors:

J. Rosh1, D. Turner2, A. Griffiths3, D. Jacobstein4, O. Adedokun5, L. Padgett5, N. Terry5, C. O’Brien5, J. Hyams6

Created: Thursday, 30 January 2020, 10:12 AM